These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 551864)

  • 1. [Clinical features and treatment of tardive dyskinesia (author's transl)].
    Shen YC
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1979; 12(1):11-3. PubMed ID: 551864
    [No Abstract]   [Full Text] [Related]  

  • 2. The dyskinesia identification system--Coldwater (DIS-Co): a tardive dyskinesia rating scale for the developmentally disabled.
    Sprague RL; Kalachnik JE; Breuning SE; Davis VJ; Ullmann RK; Cullari S; Davidson NA; Ferguson DG; Hoffner BA
    Psychopharmacol Bull; 1984; 20(2):328-38. PubMed ID: 6728999
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tardive dyskinesia after low doses of neuroleptics and attempts at treatment].
    Marsálek M
    Cesk Psychiatr; 1989 Apr; 85(2):100-5. PubMed ID: 2567213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia.
    Rabins PV; Tune LE; McHugh PR
    Johns Hopkins Med J; 1981 May; 148(5):206-11. PubMed ID: 6112284
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of 37 cases of tardive dyskinesia by deanol].
    Cai N
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):234-6. PubMed ID: 4075918
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
    J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coping with a drug-induced movement disorder: tardive dyskinesia.
    Kane JM
    Geriatrics; 1982 Dec; 37(12):83-7. PubMed ID: 6128289
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of tardive dyskinesia as measured on the Dyskinesia Identification System--Coldwater.
    Bostrom AC; Walker MK
    Nurs Res; 1990; 39(5):274-9. PubMed ID: 2399131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations in tardive dyskinesia.
    Mehta D; Eaton J; Burch M; Mehta S
    J Clin Psychiatry; 1985 Feb; 46(2):73. PubMed ID: 3968051
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxypertine in tardive dyskinesia.
    O'Shea B; Falvey J
    Ir Med J; 1985 Jul; 78(7):202-3. PubMed ID: 2863234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clonazepam in the treatment of tardive dyskinesia].
    Alecu C; Mărcuţiu V; Pruskauer-Apostol B; Voiculescu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(4):285-9. PubMed ID: 6241738
    [No Abstract]   [Full Text] [Related]  

  • 13. Tardive dyskinesia from a neurological point of view.
    Starý O
    Act Nerv Super (Praha); 1981 Dec; 23(4):300-1. PubMed ID: 6121441
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tardive dyskinesia (apropos of 3 cases)].
    Kiełczawa J; Rymaszewska G
    Psychiatr Pol; 1979; 13(5):505-9. PubMed ID: 160055
    [No Abstract]   [Full Text] [Related]  

  • 15. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
    J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol in the treatment of tardive dyskinesia.
    Perényi A; Farkas A
    Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627
    [No Abstract]   [Full Text] [Related]  

  • 17. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of cyproheptadine (Periactin) in tardive dyskinesia [proceedings].
    Gardos G; Cole JO
    Psychopharmacol Bull; 1978 Apr; 14(2):18-20. PubMed ID: 349599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.